Top

Published in:

Open Access 28-04-2022 | Type 2 Diabetes | Review

Lessons from single-cell RNA sequencing of human islets

Authors: Mtakai Ngara, Nils Wierup

Published in: Diabetologia | Issue 8/2022

Abstract

Islet dysfunction is central in type 2 diabetes and full-blown type 2 diabetes develops first when the beta cells lose their ability to secrete adequate amounts of insulin in response to raised plasma glucose. Several mechanisms behind beta cell dysfunction have been put forward but many important questions still remain. Furthermore, our understanding of the contribution of each islet cell type in type 2 diabetes pathophysiology has been limited by technical boundaries. Closing this knowledge gap will lead to a leap forward in our understanding of the islet as an organ and potentially lead to improved treatments. The development of single-cell RNA sequencing (scRNAseq) has led to a breakthrough for characterising the transcriptome of each islet cell type and several important observations on the regulation of cell-type-specific gene expression have been made. When it comes to identifying type 2 diabetes disease mechanisms, the outcome is still limited. Several studies have identified differentially expressed genes, although there is very limited consensus between the studies. As with all new techniques, scRNAseq has limitations; in addition to being extremely expensive, genes expressed at low levels may not be detected, noise may not be appropriately filtered and selection biases for certain cell types are at hand. Furthermore, recent advances suggest that commonly used computational tools may be suboptimal for analysis of scRNAseq data in small-scale studies. Fortunately, development of new computational tools holds promise for harnessing the full potential of scRNAseq data. Here we summarise how scRNAseq has contributed to increasing the understanding of various aspects of islet biology as well as type 2 diabetes disease mechanisms. We also focus on challenges that remain and propose steps to promote the utilisation of the full potential of scRNAseq in this area.

Graphical abstract

Available only for authorised users

Weir GC, Bonner-Weir S (2013) Islet β cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci 1281:92–105. https://doi.org/10.1111/nyas.12031CrossRefPubMedPubMedCentral

De Jesus DF, Kulkarni RN (2019) "Omics" and "epi-omics" underlying the β-cell adaptation to insulin resistance. Mol Metab 27S:S42–S48. https://doi.org/10.1016/j.molmet.2019.06.003CrossRefPubMed

Wierup N, Sundler F, Heller RS (2014) The islet ghrelin cell. J Mol Endocrinol 52(1):R35–R49. https://doi.org/10.1530/JME-13-0122CrossRefPubMed

Walker JT, Saunders DC, Brissova M, Powers AC (2021) The human islet: mini-organ with mega-impact. Endocr Rev 42(5):605–657. https://doi.org/10.1210/endrev/bnab010CrossRefPubMedPubMedCentral

Marchetti P, Suleiman M, De Luca C et al (2020) A direct look at the dysfunction and pathology of the beta cells in human type 2 diabetes. Semin Cell Dev Biol 103:83–93. https://doi.org/10.1016/j.semcdb.2020.04.005CrossRefPubMed

Rorsman P, Ashcroft FM (2018) Pancreatic beta-cell electrical activity and insulin secretion: of mice and men. Physiol Rev 98(1):117–214. https://doi.org/10.1152/physrev.00008.2017CrossRefPubMed

Han X, Wang R, Zhou Y et al (2018) Mapping the mouse cell atlas by microwell-Seq. Cell 172(5):1091–1107.e1017. https://doi.org/10.1016/j.cell.2018.02.001CrossRefPubMed

Schaum N, Karkanias J, Neff NF et al (2018) Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562(7727):367–372. https://doi.org/10.1038/s41586-018-0590-4CrossRefPubMedCentral

Howick VM, Russell AJC, Andrews T et al (2019) The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle. Science 365(6455). https://doi.org/10.1126/science.aaw2619

10.

Larsson AJM, Johnsson P, Hagemann-Jensen M et al (2019) Genomic encoding of transcriptional burst kinetics. Nature 565(7738):251–254. https://doi.org/10.1038/s41586-018-0836-1CrossRefPubMedPubMedCentral

11.

Hagemann-Jensen M, Ziegenhain C, Chen P et al (2020) Single-cell RNA counting at allele and isoform resolution using smart-seq3. Nat Biotechnol 38(6):708–714. https://doi.org/10.1038/s41587-020-0497-0CrossRefPubMed

12.

Bergen V, Lange M, Peidli S, Wolf FA, Theis FJ (2020) Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol 38(12):1408–1414. https://doi.org/10.1038/s41587-020-0591-3CrossRefPubMed

13.

La Manno G, Soldatov R, Zeisel A et al (2018) RNA velocity of single cells. Nature 560(7719):494–498. https://doi.org/10.1038/s41586-018-0414-6CrossRefPubMedPubMedCentral

14.

Wang YJ, Schug J, Won KJ et al (2016) Single-cell transcriptomics of the human endocrine pancreas. Diabetes 65(10):3028–3038. https://doi.org/10.2337/db16-0405CrossRefPubMedPubMedCentral

15.

Camunas-Soler J, Dai XQ, Hang Y et al (2020) Patch-Seq links single-cell transcriptomes to human islet dysfunction in diabetes. Cell Metab 31(5):1017–1031 e1014. https://doi.org/10.1016/j.cmet.2020.04.005CrossRefPubMedPubMedCentral

16.

Lawlor N, George J, Bolisetty M et al (2017) Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res 27(2):208–222. https://doi.org/10.1101/gr.212720.116CrossRefPubMedPubMedCentral

17.

Segerstolpe A, Palasantza A, Eliasson P et al (2016) Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab 24(4):593–607. https://doi.org/10.1016/j.cmet.2016.08.020CrossRefPubMedPubMedCentral

18.

Xin Y, Kim J, Okamoto H et al (2016) RNA sequencing of single human islet cells reveals type 2 diabetes genes. Cell Metab 24(4):608–615. https://doi.org/10.1016/j.cmet.2016.08.018CrossRefPubMed

19.

Fang Z, Weng C, Li H et al (2019) Single-cell heterogeneity analysis and CRISPR screen identify key beta-cell-specific disease genes. Cell Rep 26(11):3132–3144 e3137. https://doi.org/10.1016/j.celrep.2019.02.043CrossRefPubMedPubMedCentral

20.

Muraro MJ, Dharmadhikari G, Grun D et al (2016) A single-cell transcriptome atlas of the human pancreas. Cell Syst 3(4):385–394 e383. https://doi.org/10.1016/j.cels.2016.09.002CrossRefPubMedPubMedCentral

21.

Baron M, Veres A, Wolock SL et al (2016) A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst 3(4):346–360 e344. https://doi.org/10.1016/j.cels.2016.08.011CrossRefPubMedPubMedCentral

22.

Enge M, Arda HE, Mignardi M et al (2017) Single-cell analysis of human pancreas reveals transcriptional signatures of aging and somatic mutation patterns. Cell 171(2):321–330 e314. https://doi.org/10.1016/j.cell.2017.09.004CrossRefPubMedPubMedCentral

23.

Li J, Klughammer J, Farlik M et al (2016) Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types. EMBO Rep 17(2):178–187. https://doi.org/10.15252/embr.201540946CrossRefPubMed

24.

Dominguez Gutierrez G, Kim J, Lee AH et al (2018) Gene signature of the human pancreatic epsilon cell. Endocrinology 159(12):4023–4032. https://doi.org/10.1210/en.2018-00833CrossRefPubMedPubMedCentral

25.

Dorajoo R, Ali Y, Tay VSY et al (2017) Single-cell transcriptomics of east-Asian pancreatic islets cells. Sci Rep 7(1):5024. https://doi.org/10.1038/s41598-017-05266-4CrossRefPubMedPubMedCentral

26.

Dominguez Gutierrez G, Xin Y, Okamoto H et al (2018) Gene signature of proliferating human pancreatic alpha cells. Endocrinology 159(9):3177–3186. https://doi.org/10.1210/en.2018-00469CrossRefPubMed

27.

Xin Y, Dominguez Gutierrez G, Okamoto H et al (2018) Pseudotime ordering of single human beta-cells reveals states of insulin production and unfolded protein response. Diabetes 67(9):1783–1794. https://doi.org/10.2337/db18-0365CrossRefPubMed

28.

Grün D, Muraro MJ, Boisset JC et al (2016) De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell 19(2):266–277. https://doi.org/10.1016/j.stem.2016.05.010CrossRefPubMedPubMedCentral

29.

Basile G, Kahraman S, Dirice E, Pan H, Dreyfuss JM, Kulkarni RN (2021) Using single-nucleus RNA-sequencing to interrogate transcriptomic profiles of archived human pancreatic islets. Genome Med 13(1):128. https://doi.org/10.1186/s13073-021-00941-8CrossRefPubMedPubMedCentral

30.

Li J, Casteels T, Frogne T et al (2017) Artemisinins target GABAA receptor signaling and impair alpha cell identity. Cell 168(1–2):86–100 e115. https://doi.org/10.1016/j.cell.2016.11.010CrossRefPubMedPubMedCentral

31.

Marquina-Sanchez B, Fortelny N, Farlik M et al (2020) Single-cell RNA-seq with spike-in cells enables accurate quantification of cell-specific drug effects in pancreatic islets. Genome Biol 21(1):106. https://doi.org/10.1186/s13059-020-02006-2CrossRefPubMedPubMedCentral

32.

Avrahami D, Wang YJ, Schug J et al (2020) Single-cell transcriptomics of human islet ontogeny defines the molecular basis of beta-cell dedifferentiation in T2D. Mol Metab 42:101057. https://doi.org/10.1016/j.molmet.2020.101057CrossRefPubMedPubMedCentral

33.

Mawla AM, Huising MO (2019) Navigating the depths and avoiding the shallows of pancreatic islet cell transcriptomes. Diabetes 68(7):1380–1393. https://doi.org/10.2337/dbi18-0019CrossRefPubMedPubMedCentral

34.

Svensson V (2020) Droplet scRNA-seq is not zero-inflated. Nat Biotechnol 38(2):147–150. https://doi.org/10.1038/s41587-019-0379-5CrossRefPubMed

35.

Avrahami D, Wang YJ, Klochendler A, Dor Y, Glaser B, Kaestner KH (2017) beta-cells are not uniform after all-novel insights into molecular heterogeneity of insulin-secreting cells. Diabetes Obes Metab 19(Suppl 1):147–152. https://doi.org/10.1111/dom.13019CrossRefPubMedPubMedCentral

36.

Wang YJ, Kaestner KH (2019) Single-cell RNA-Seq of the pancreatic islets--a promise not yet fulfilled? Cell Metab 29(3):539–544. https://doi.org/10.1016/j.cmet.2018.11.016CrossRefPubMed

37.

Joglekar MV, Dong CX, Wong WKM, Dalgaard LT, Hardikar AA (2021) A bird's eye view of the dynamics of pancreatic beta-cell heterogeneity. Acta Physiol (Oxf) 233(2):e13664. https://doi.org/10.1111/apha.13664CrossRef

38.

Barkas N, Petukhov V, Nikolaeva D et al (2019) Joint analysis of heterogeneous single-cell RNA-seq dataset collections. Nat Methods 16(8):695–698. https://doi.org/10.1038/s41592-019-0466-zCrossRefPubMedPubMedCentral

39.

Baron CS, Barve A, Muraro MJ et al (2019) Cell type purification by single-cell transcriptome-trained sorting. Cell 179(2):527–542 e519. https://doi.org/10.1016/j.cell.2019.08.006CrossRefPubMedPubMedCentral

40.

Qadir MMF, Alvarez-Cubela S, Klein D et al (2020) Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche. Proc Natl Acad Sci U S A 117(20):10876–10887. https://doi.org/10.1073/pnas.1918314117CrossRefPubMedPubMedCentral

41.

Fadista J, Vikman P, Laakso EO et al (2014) Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A 111(38):13924–13929. https://doi.org/10.1073/pnas.1402665111CrossRefPubMedPubMedCentral

42.

Lindqvist A, Shcherbina L, Prasad RB et al (2020) Ghrelin suppresses insulin secretion in human islets and type 2 diabetes patients have diminished islet ghrelin cell number and lower plasma ghrelin levels. Mol Cell Endocrinol 511:110835. https://doi.org/10.1016/j.mce.2020.110835CrossRefPubMed

43.

Squair JW, Gautier M, Kathe C et al (2021) Confronting false discoveries in single-cell differential expression. Nat Commun 12(1):5692. https://doi.org/10.1038/s41467-021-25960-2CrossRefPubMedPubMedCentral

44.

Arystarkhova E, Liu YB, Salazar C et al (2013) Hyperplasia of pancreatic beta cells and improved glucose tolerance in mice deficient in the FXYD2 subunit of Na,K-ATPase. J Biol Chem 288(10):7077–7085. https://doi.org/10.1074/jbc.M112.401190CrossRefPubMedPubMedCentral

45.

Ahlqvist E, Storm P, Karajamaki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361–369. https://doi.org/10.1016/S2213-8587(18)30051-2CrossRefPubMed

46.

Marx V (2021) Method of the year: spatially resolved transcriptomics. Nat Methods 18(1):9–14. https://doi.org/10.1038/s41592-020-01033-yCrossRefPubMed

47.

Kharchenko PV (2021) The triumphs and limitations of computational methods for scRNA-seq. Nat Methods 18(7):723–732. https://doi.org/10.1038/s41592-021-01171-xCrossRefPubMed

48.

Balboa D, Saarimaki-Vire J, Borshagovski D et al (2018) Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. Elife 7. https://doi.org/10.7554/eLife.38519

49.

Choobdar S, Ahsen ME, Crawford J et al (2019) Assessment of network module identification across complex diseases. Nat Methods 16(9):843–852. https://doi.org/10.1038/s41592-019-0509-5CrossRefPubMedPubMedCentral

50.

Saelens W, Cannoodt R, Saeys Y (2018) A comprehensive evaluation of module detection methods for gene expression data. Nat Commun 9(1):1090. https://doi.org/10.1038/s41467-018-03424-4CrossRefPubMedPubMedCentral

51.

Lichtblau Y, Zimmermann K, Haldemann B, Lenze D, Hummel M, Leser U (2017) Comparative assessment of differential network analysis methods. Brief Bioinform 18(5):837–850. https://doi.org/10.1093/bib/bbw061CrossRefPubMed

52.

Asplund O, Storm P, Chandra V et al (2020) Islet Gene View - a tool to facilitate islet research. bioRxiv: 435743. https://doi.org/10.1101/435743

53.

Bosi E, Marselli L, De Luca C et al (2020) Integration of single-cell datasets reveals novel transcriptomic signatures of beta-cells in human type 2 diabetes. NAR Genom Bioinform 2(4):lqaa097. https://doi.org/10.1093/nargab/lqaa097CrossRefPubMedPubMedCentral

54.

Xin Y, Kim J, Ni M et al (2016) Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. Proc Natl Acad Sci U S A 113(12):3293–3298. https://doi.org/10.1073/pnas.1602306113CrossRefPubMedPubMedCentral

55.

Tabula Muris C, Overall C, Logistical C et al (2018) Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562(7727):367–372. https://doi.org/10.1038/s41586-018-0590-4CrossRef

56.

Zakharov PN, Hu H, Wan X, Unanue ER (2020) Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J Exp Med 217(6). https://doi.org/10.1084/jem.20192362

57.

Chakravarthy H, Gu X, Enge M et al (2017) Converting adult pancreatic islet alpha cells into beta cells by targeting both Dnmt1 and Arx. Cell Metab 25(3):622–634. https://doi.org/10.1016/j.cmet.2017.01.009CrossRefPubMedPubMedCentral

58.

Stanescu DE, Yu R, Won KJ, Stoffers DA (2017) Single cell transcriptomic profiling of mouse pancreatic progenitors. Physiol Genomics 49(2):105–114. https://doi.org/10.1152/physiolgenomics.00114.2016CrossRefPubMed

59.

Li LC, Qiu WL, Zhang YW et al (2018) Single-cell transcriptomic analyses reveal distinct dorsal/ventral pancreatic programs. EMBO Rep 19(10). https://doi.org/10.15252/embr.201846148

60.

Qiu WL, Zhang YW, Feng Y, Li LC, Yang L, Xu CR (2018) Deciphering pancreatic islet beta cell and alpha cell maturation pathways and characteristic features at the single-cell level. Cell Metab 27(3):702. https://doi.org/10.1016/j.cmet.2018.01.017CrossRefPubMed

61.

Scavuzzo MA, Hill MC, Chmielowiec J et al (2018) Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis. Nat Commun 9(1):3356. https://doi.org/10.1038/s41467-018-05740-1CrossRefPubMedPubMedCentral

62.

Zeng C, Mulas F, Sui Y et al (2017) Pseudotemporal ordering of single cells reveals metabolic control of postnatal beta cell proliferation. Cell Metab 25(5):1160–1175 e1111. https://doi.org/10.1016/j.cmet.2017.04.014CrossRefPubMedPubMedCentral

63.

Fasolino M, Schwartz GW, Patil AR et al (2022) Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes. Nat Metab 4:284–299. https://doi.org/10.1038/s42255-022-00531-x

64.

Petersen MBK, Azad A, Ingvorsen C et al (2017) Single-cell gene expression analysis of a human ESC model of pancreatic endocrine development reveals different paths to beta-cell differentiation. Stem Cell Rep 9(4):1246–1261. https://doi.org/10.1016/j.stemcr.2017.08.009CrossRef

65.

Veres A, Faust AL, Bushnell HL et al (2019) Charting cellular identity during human in vitro beta-cell differentiation. Nature 569(7756):368–373. https://doi.org/10.1038/s41586-019-1168-5CrossRefPubMedPubMedCentral

66.

Weng C, Xi J, Li H et al (2020) Single-cell lineage analysis reveals extensive multimodal transcriptional control during directed beta-cell differentiation. Nat Metab 2(12):1443–1458. https://doi.org/10.1038/s42255-020-00314-2CrossRefPubMedPubMedCentral

67.

Augsornworawat P, Maxwell KG, Velazco-Cruz L, Millman JR (2020) Single-cell transcriptome profiling reveals beta cell maturation in stem cell-derived islets after transplantation. Cell Rep 32(8):108067. https://doi.org/10.1016/j.celrep.2020.108067CrossRefPubMedPubMedCentral

68.

Alumets J, Hakanson R, Sundler F (1983) Ontogeny of endocrine cells in porcine gut and pancreas. An immunocytochemical study. Gastroenterology 85(6):1359–1372CrossRef

69.

Prasad RB, Groop L (2015) Genetics of type 2 diabetes-pitfalls and possibilities. Genes 6(1):87–123. https://doi.org/10.3390/genes6010087CrossRefPubMedPubMedCentral

70.

Zhou Y, Park SY, Su J et al (2014) TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet 23(24):6419–6431. https://doi.org/10.1093/hmg/ddu359CrossRefPubMedPubMedCentral

Title: Lessons from single-cell RNA sequencing of human islets
Authors: Mtakai Ngara
Nils Wierup
Publication date: 28-04-2022
Publisher: Springer Berlin Heidelberg
Keyword: Type 2 Diabetes
Published in: Diabetologia / Issue 8/2022
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-022-05699-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 8/2022

Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG

Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetes

Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes

IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials